Who owns the SIMLANDI trademark?

The SIMLANDI trademark is owned by Teva Pharmaceuticals USA, Inc..

What is the serial number for SIMLANDI?

The USPTO serial number for SIMLANDI is 79291859.

What is the registration number for SIMLANDI?

SIMLANDI is registered under USPTO registration number 6481024.

SIM

USPTO Trademark Record

REGISTERED

SIMLANDI

Q: What class is the SIMLANDI trademark registered in?

The SIMLANDI trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

SN 79291859·Reg 6481024·Filed May 12, 2020

Owner Teva Pharmaceuticals USA, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

SIMLANDI (Serial No. 79291859), Registration No. 6481024, is a registered US trademark filed on May 12, 2020 by Teva Pharmaceuticals USA, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

Renewal window: September 14, 2027353 days remaining

Mark Intelligence

SIMLANDI (Reg. #6481024) is a registered US trademark that has been protecting its owner, Teva Pharmaceuticals USA, Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 010 (Surgical, medical, dental & veterinary apparatus) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 12, 2020

SERIAL

79291859

REG#

6481024

REGISTERED

Sep 14, 2021

Owner

Applicant

Teva Pharmaceuticals USA, Inc.

Entity

Corporation

State

Address

400 Interpace Parkway, Building A, Parsippany, NJ, 07054

Country

Attorney

NameLori Wolfe

Law firm

Lori Wolfe Teva Pharmaceuticals USA, Inc.

Address

400 Interpace Parkway, Building A, Parsippany, NJ 07054, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 12, 2020

Serial Number79291859

Registration No.6481024

Registration DateSep 14, 2021

Status DateSep 14, 2021

Published for OppositionJun 29, 2021

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 010Surgical, medical, dental & veterinary apparatus

US codes: 026, 039, 044

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

32 events

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 04, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 04, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 04, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 04, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 04, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Apr 17, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Feb 28, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Feb 28, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Dec 14, 2021

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Sep 14, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jun 29, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 29, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 09, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

May 24, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 24, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 24, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 24, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 24, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

May 21, 2021

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 21, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 21, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

CHANGE OF OWNER RECEIVED FROM IB

Dec 24, 2020

CHANGE OF OWNER RECEIVED FROM IB

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 09, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

REFUSAL PROCESSED BY IB

Oct 19, 2020

REFUSAL PROCESSED BY IB

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Sep 30, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

REFUSAL PROCESSED BY MPU

Sep 29, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 30, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Aug 29, 2020

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

Aug 25, 2020

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 21, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Aug 21, 2020

ASSIGNED TO EXAMINER

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 20, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

SIMLANDI

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Teva Pharmaceuticals USA, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Lori Wolfe

Resources

Company